TAM
Trust Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $637K | Hold |
1,213
| – | – | 0.05% | 125 |
|
|
2025
Q1 | $769K | Sell |
1,213
-24
| -2% | -$15.2K | 0.06% | 103 |
|
|
2024
Q4 | $881K | Hold |
1,237
| – | – | 0.07% | 99 |
|
|
2024
Q3 | $1.3M | Hold |
1,237
| – | – | 0.1% | 72 |
|
|
2024
Q2 | $1.3M | Hold |
1,237
| – | – | 0.11% | 70 |
|
|
2024
Q1 | $1.19M | Hold |
1,237
| – | – | 0.1% | 76 |
|
|
2023
Q4 | $1.09M | Hold |
1,237
| – | – | 0.1% | 76 |
|
|
2023
Q3 | $1.02M | Hold |
1,237
| – | – | 0.11% | 74 |
|
|
2023
Q2 | $889K | Hold |
1,237
| – | – | 0.09% | 83 |
|
|
2023
Q1 | $1.02M | Buy |
1,237
+18
| +1% | +$14.8K | 0.11% | 71 |
|
|
2022
Q4 | $879K | Hold |
1,219
| – | – | 0.11% | 78 |
|
|
2022
Q3 | $840K | Buy |
1,219
+95
| +8% | +$65.5K | 0.11% | 72 |
|
|
2022
Q2 | $664K | Buy |
1,124
+72
| +7% | +$42.5K | 0.09% | 86 |
|
|
2022
Q1 | $735K | Buy |
1,052
+48
| +5% | +$33.5K | 0.09% | 89 |
|
|
2021
Q4 | $634K | Hold |
1,004
| – | – | 0.08% | 98 |
|
|
2021
Q3 | $608K | Buy |
1,004
+68
| +7% | +$41.2K | 0.08% | 101 |
|
|
2021
Q2 | $523K | Buy |
936
+103
| +12% | +$57.6K | 0.07% | 102 |
|
|
2021
Q1 | $394K | Buy |
833
+150
| +22% | +$70.9K | 0.05% | 118 |
|
|
2020
Q4 | $330K | Buy |
683
+172
| +34% | +$83.1K | 0.05% | 112 |
|
|
2020
Q3 | $286K | Buy |
+511
| New | +$286K | 0.05% | 91 |
|